cisatracurium besylate
cisatracurium besylate is listed in the FDA National Drug Code directory with 9 NDC codes, marketed under brand names including cisatracurium besylate, Cisatracurium Besylate. Available dosage forms: injection, powder, injection, solution.
Drug Details
- Generic Name
- cisatracurium besylate
- Brand Names
- cisatracurium besylate, Cisatracurium Besylate
- Application Number
- ANDA212171
- Sponsor
- Zydus Pharmaceuticals USA Inc.
- NDC Codes
- 9
- Dosage Forms
- INJECTION, POWDER, INJECTION, SOLUTION
- Routes
- INTRAVENOUS
- Active Ingredients
- CISATRACURIUM BESYLATE
Indications and Usage
1 INDICATIONS AND USAGE Cisatracurium besylate injection is indicated: • as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients 1 month to 12 years of age • to provide skeletal muscle relaxation in adults during surgical procedures or during mechanical ventilation in the ICU • to provide skeletal muscle relaxation during surgical procedures via infusion in pediatric patients 2 years and older. Limitations of Use Cisatracurium besylate injection is not recommended for rapid sequence endotracheal intubation due to the time required for its onset of action. Cisatracurium besylate is a nondepolarizing neuromuscular blocker indicated: • as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients 1 month to 12 years of age ( 1 ) • to provide skeletal muscle relaxation during surgery in adults and in pediatric patients 2 to 12 years of age as a bolus or infusion maintenance ( 1 ) • for mechanical ventilation in the ICU in adults ( 1 ) Limitations of Use Cisatracurium besylate is not recommended for rapid sequence endotracheal intubation due to the time required for its onset of action (1)